CABG vs. Drug-Eluting Stents in Patients with Multivessel CAD

摘要

The two primary interventions for patients with multivessel coronary artery disease (CAD) are coronary artery bypass grafting (CABG) and stenting by percutaneous coronary intervention (PCI). Subgroup analysis for high-risk patients with diabetes mellitus, ejection fractions below 40 percent, or age of at least 80 years showed no significant differences in mortality between those receiving CABG and drug-eluting stents, but the latter two subgroups treated with CABG did have lower rates of the combined end point of death or myocardial infarction.